The docetaxel (DOC) and gemcitabine (GEM) combination as adjuvant chemotherapy in patients with non-small cell lung cancer (NSCLC): A multi-institutional phase II trial

Terumoto Koike, Keisuke Eguchi, Yuichi Izumi et al.|Journal of Clinical Oncology|2006

Cited by 0